DK2125714T3 - Hydrochloridsalt af 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid - Google Patents

Hydrochloridsalt af 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid

Info

Publication number: DK2125714T3
Authority: DK; Denmark
Prior art keywords: diphenylhexanamide; hydroxyphenoxy; azetidin; methyl; hydrochloride salt
Prior art date: 2007-03-16

Application number

DK08719316.5T

Other languages

English (en)

Inventor

Paul Alan Glossop

Kim James

Original Assignee

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-16

Filing date

2008-03-06

Publication date

2011-07-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39591485&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2125714(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-06 Application filed by Pfizer Ltd filed Critical Pfizer Ltd

2011-07-25 Application granted granted Critical

2011-07-25 Publication of DK2125714T3 publication Critical patent/DK2125714T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DK08719316.5T 2007-03-16 2008-03-06 Hydrochloridsalt af 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid DK2125714T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US89516307P	2007-03-16	2007-03-16
PCT/IB2008/000622 WO2008135819A1 (en)	2007-03-16	2008-03-06	Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide

Publications (1)

Publication Number	Publication Date
DK2125714T3 true DK2125714T3 (da)	2011-07-25

Family

ID=39591485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08719316.5T DK2125714T3 (da)	2007-03-16	2008-03-06	Hydrochloridsalt af 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid

Country Status (24)

Country	Link
US (1)	US8263583B2 (da)
EP (1)	EP2125714B1 (da)
JP (1)	JP4277051B2 (da)
KR (1)	KR101120227B1 (da)
CN (2)	CN101641327A (da)
AR (1)	AR065714A1 (da)
AT (1)	ATE512132T1 (da)
AU (1)	AU2008247095B2 (da)
BR (1)	BRPI0808413A2 (da)
CA (1)	CA2678683C (da)
CY (1)	CY1111701T1 (da)
DK (1)	DK2125714T3 (da)
ES (1)	ES2364727T3 (da)
HK (1)	HK1189591A1 (da)
IL (1)	IL200403A (da)
MX (1)	MX2009009952A (da)
NZ (1)	NZ579056A (da)
PL (1)	PL2125714T3 (da)
PT (1)	PT2125714E (da)
RU (1)	RU2422439C2 (da)
SI (1)	SI2125714T1 (da)
TW (1)	TWI348907B (da)
WO (1)	WO2008135819A1 (da)
ZA (1)	ZA200906462B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2504352B1 (en)	2009-11-23	2018-11-14	Palatin Technologies, Inc.	Melanocortin-1 receptor-specific cyclic peptides
CN102712674A (zh)	2009-11-23	2012-10-03	帕拉丁科技公司	黑皮质素-1受体-特异性的线性肽
EP2578570A1 (en)	2011-10-07	2013-04-10	Almirall, S.A.	Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en)	2012-03-20	2013-09-25	Almirall, S.A.	Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP3596046A1 (en) *	2017-03-15	2020-01-22	Mylan Laboratories Ltd.	Novel polymorphs of (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide hydrochloride
DK3691620T3 (da)	2017-10-05	2022-10-03	Fulcrum Therapeutics Inc	P38-kinaseinhibitor reducerer dux4- og downstream-gen-ekspression til behandling af fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2020261160A1 (en) *	2019-06-25	2020-12-30	Mylan Laboratories Limited	Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
WO2021260441A1 (en) *	2020-06-26	2021-12-30	Mylan Pharma Uk Limited	Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
CN113577059B (zh) *	2021-08-02	2022-05-20	山东大学齐鲁医院(青岛)	一种用于小儿哮喘的活性药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1104239C (zh) *	1996-12-02	2003-04-02	杏林制药株式会社	新颖的n－取代的吡咯烷衍生物及其制备方法
JPH11100366A (ja)	1997-09-29	1999-04-13	Kyorin Pharmaceut Co Ltd	新規ｎ−置換環状アミン誘導体及びその製造法
EA013083B1 (ru) *	2005-09-21	2010-02-26	Пфайзер Лимитед	Карбоксамидные производные в качестве антагонистов мускариновых рецепторов
WO2008035157A1 (en) *	2006-09-22	2008-03-27	Pfizer Limited	Azetidine derivatives as muscarinic receptor antagonists

2008
- 2008-03-06 CN CN200880008581A patent/CN101641327A/zh active Pending
- 2008-03-06 MX MX2009009952A patent/MX2009009952A/es active IP Right Grant
- 2008-03-06 AU AU2008247095A patent/AU2008247095B2/en active Active
- 2008-03-06 PT PT08719316T patent/PT2125714E/pt unknown
- 2008-03-06 WO PCT/IB2008/000622 patent/WO2008135819A1/en active Application Filing
- 2008-03-06 CA CA2678683A patent/CA2678683C/en active Active
- 2008-03-06 ES ES08719316T patent/ES2364727T3/es active Active
- 2008-03-06 SI SI200830366T patent/SI2125714T1/sl unknown
- 2008-03-06 NZ NZ579056A patent/NZ579056A/en unknown
- 2008-03-06 US US12/530,573 patent/US8263583B2/en active Active
- 2008-03-06 KR KR1020097019239A patent/KR101120227B1/ko active IP Right Grant
- 2008-03-06 DK DK08719316.5T patent/DK2125714T3/da active
- 2008-03-06 CN CN201310280277.XA patent/CN103351367B/zh active Active
- 2008-03-06 AT AT08719316T patent/ATE512132T1/de active
- 2008-03-06 PL PL08719316T patent/PL2125714T3/pl unknown
- 2008-03-06 EP EP08719316A patent/EP2125714B1/en active Active
- 2008-03-06 RU RU2009134512/04A patent/RU2422439C2/ru active
- 2008-03-06 BR BRPI0808413-0A patent/BRPI0808413A2/pt not_active Application Discontinuation
- 2008-03-13 AR ARP080101025A patent/AR065714A1/es not_active Application Discontinuation
- 2008-03-14 JP JP2008065066A patent/JP4277051B2/ja active Active
- 2008-03-14 TW TW097109223A patent/TWI348907B/zh active
2009
- 2009-08-13 IL IL200403A patent/IL200403A/en not_active IP Right Cessation
- 2009-09-16 ZA ZA200906462A patent/ZA200906462B/xx unknown
2011
- 2011-07-08 CY CY20111100664T patent/CY1111701T1/el unknown
2014
- 2014-03-18 HK HK14102704.7A patent/HK1189591A1/xx unknown

Also Published As

Publication number	Publication date
ATE512132T1 (de)	2011-06-15
SI2125714T1 (sl)	2011-10-28
WO2008135819A1 (en)	2008-11-13
JP2009001543A (ja)	2009-01-08
ZA200906462B (en)	2010-06-30
EP2125714B1 (en)	2011-06-08
CN101641327A (zh)	2010-02-03
AR065714A1 (es)	2009-06-24
US20100113409A1 (en)	2010-05-06
CA2678683A1 (en)	2008-11-13
RU2422439C2 (ru)	2011-06-27
BRPI0808413A2 (pt)	2014-07-15
CY1111701T1 (el)	2015-10-07
AU2008247095A1 (en)	2008-11-13
IL200403A0 (en)	2010-04-29
US8263583B2 (en)	2012-09-11
AU2008247095B2 (en)	2012-12-13
PL2125714T3 (pl)	2011-10-31
HK1189591A1 (en)	2014-06-13
PT2125714E (pt)	2011-07-14
NZ579056A (en)	2011-07-29
CN103351367B (zh)	2015-06-10
CN103351367A (zh)	2013-10-16
KR101120227B1 (ko)	2012-03-20
MX2009009952A (es)	2009-10-08
EP2125714A1 (en)	2009-12-02
JP4277051B2 (ja)	2009-06-10
KR20090110944A (ko)	2009-10-23
IL200403A (en)	2014-08-31
ES2364727T3 (es)	2011-09-13
RU2009134512A (ru)	2011-03-20
TWI348907B (en)	2011-09-21
TW200904408A (en)	2009-02-01
WO2008135819A8 (en)	2009-08-27
CA2678683C (en)	2012-05-15

Publication	Publication Date	Title
DK2125714T3 (da)	2011-07-25	Hydrochloridsalt af 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid
BRPI0815440A2 (pt)	2017-05-30	5-substituidos 2- (alcoximetil) furanos
BRPI0914772A2 (pt)	2015-10-20	compostos heterocíclicos 1,2-dissubstituídos
BRPI0817537A2 (pt)	2015-03-31	4-[3-(4-ciclopropanocarbonil-piperazina-i-carboni-,-fl uoro-benzil]-2h-ftalazin-1-ona
BRPI0811578A2 (pt)	2014-12-09	Tetramatos substituídos por 3-(2-alcóxi-fenila)
BRPI0811280A2 (pt)	2015-01-20	Compostos amino-heterocíclicos
BRPI0818457A2 (pt)	2015-04-14	Derivados de oxadiazol
BRPI0910909A2 (pt)	2015-09-29	compensador de balouço passivo submarino compensado em profundidade.
BRPI0923786A2 (pt)	2016-07-26	compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
RU2465270C3 (ru)	2017-03-28	Полиморфная форма 4-[3-(4-циклопропанкарбонилпиперазин-1-карбонил)-4-фторбензил]-2н-фталазин-1-она
BRPI0916233A2 (pt)	2018-03-13	compostos heterocíclicos antivirais
ATE484507T1 (de)	2010-10-15	Heterocyclische spiroverbindungen
DK2049487T3 (da)	2013-02-18	Fremgangsmåde til fremstilling af 2-substituerede 5-(1-alkylthio)alkylpyridiner
BRPI0906705A2 (pt)	2015-06-30	Composto heterocíclicos
BRPI0812354A2 (pt)	2015-01-27	Composição farmacêutica não-aquosa.
BRPI0915047A2 (pt)	2015-08-11	Composição herbicida
BRPI0908731A2 (pt)	2017-05-16	formas cristalinas de 5-[3-(2,5-dicloro-4,6-dimetil-1-óxi-piridina-3-il)[1,2,4]oxadiazol-5-il]-3-nitrobenzeno-1,2-diol
BRPI0821349A2 (pt)	2019-09-24	compostos antivirais heterocíclicos
BRPI0924121A2 (pt)	2019-09-24	compostos antivirais heterocíclicos
DK2142533T3 (da)	2011-12-12	Imidazolidinonderivater
BRPI0911634A2 (pt)	2016-06-14	processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas
DE602007012490D1 (de)	2011-03-31	Herbizidzusammensetzung
DK2300452T3 (da)	2014-02-17	5 -[5- [2-(3,5 -(bis(trifluoromethyl)phenyl) -2 - methylpropanoylmethylamino ]-4 -(4-fluoro -2-methylphenyl)]-2-pyridinyl -2-alkyl -prolinamid som NK1 receptor antagonister
DK2266990T3 (da)	2013-01-07	3-PHENYLPYRAZOLO(5,1-b)THIAZOLFORBINDELSE
BRPI0917014A2 (pt)	2016-02-16	utilização de pelo menos um copolímero